AUG 13, 2026 · PHASE 2 TRIAL
CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock
ClinicalTrials.gov
This is a Phase 2 pilot study not yet recruiting with a planned sample of 30 patients and a surrogate primary endpoint (hsCRP); no results are posted in this registry record.
Reported
Planned sample size30
PhasePhase 2
Primary outcome measureChange in High-Sensitivity C-Reactive Prote…